ARS Wealth Advisors Group’s GSK GSK Stock Holding History

ARS Wealth Advisors Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.69M	Buy	127,638 +122	+0.1%	+$6.45K	0.52%	42
2026 Q1	$7.04M	Buy	+127,516	New	+$6.91M	0.59%	40
2022 Q4	–	Sell	-8,194	Closed	-$241K	–	143
2022 Q3	$241K	Sell	8,194 -121,942	-94%	-$4.62M	0.04%	132
2022 Q2	$7.08M	Buy	+130,136	New	+$7.18M	0.97%	38

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

ARS Wealth Advisors Group's GSK Position: Q2 2026 in Review

ARS Wealth Advisors Group increased its GSK (GSK) stake by 0.1% in Q2 2026, buying an estimated $6.45K and bringing the position to 127,638 shares worth $6.69M. The position accounts for 0.52% of the portfolio, ranked #42.

ARS Wealth Advisors Group first reported a position in GSK in Q2 2022 and has held it in 4 quarters since. The position peaked at $7.08M in Q2 2022. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

ARS Wealth Advisors Group held 127,638 shares of GSK worth $6.69M as of Q2 2026.
ARS Wealth Advisors Group bought 122 GSK shares in Q2 2026, an estimated $6.45K.
GSK made up 0.52% of ARS Wealth Advisors Group's portfolio in Q2 2026, its #42 holding.
ARS Wealth Advisors Group first reported a position in GSK in Q2 2022 and has held it in 4 quarters since.
ARS Wealth Advisors Group's GSK position peaked at $7.08M in Q2 2022.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on ARS Wealth Advisors Group's 13F filing for Q2 2026, filed 16 Jul 2026.